1-Butylbenzo[cd]indol-2(1H)-one

Catalog No. :
ACWKGC917
CAS No. :
39273-39-7
Molecular Formula :
C15H15NO
Molecular Weight :
225.29

IUPAC Name:1-butylbenzo[cd]indol-2(1H)-one

1-Butylbenzo[cd]indol-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$54.00Login to see priceInquiryInquiry
250mg95%$81.00Login to see priceInquiryInquiry
1g95%$199.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Butylbenzo[cd]indol-2(1H)-one
IUPAC Name1-butylbenzo[cd]indol-2(1H)-one
MDL No.MFCD00722762
Molecular FormulaC15H15NO
Molecular Weight225.29
SMILESCCCCN1C(=O)C2=CC=CC3=CC=CC1=C23
InChI KeyZSBAMLODXHIFFD-UHFFFAOYSA-N
SynonymN-Butylnaphthostyril;1-butylbenzo[cd]indol-2(1H)-one;1-Butylbenzo(cd)indol-2-one;2-butyl-2-azatricyclo[6.3.1.0?,]dodeca-1(11),4(12), 5,7,9-pentaen-3-one;2-Butyl-2-azatricyclo[6.3.1.0,4,12]dodeca-1(12),4,6,8,10-pentaen-3-one;Benz[cd]indol-2(1H)-one, 1-butyl-
CAS No.39273-39-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWKGC917 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTSM908 route compound structure diagram
    ACHTSM908130-00-7 In Stock
  4. Then
  5. ACWKGC917 route product structure diagram
    ACWKGC91739273-39-7
Inquiry

2. ACWKGC917 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTSM908 route compound structure diagram
    ACHTSM908130-00-7 In Stock
  4. Then
  5. ACWKGC917 route product structure diagram
    ACWKGC91739273-39-7
Inquiry

Comments (0)